Why the study?
Arrhythmic risk in non-dilated left ventricular cardiomyopathy and the prognostic value of overlapping features with arrhythmogenic cardiomyopathy required evaluation.
Do overlapping features with arrhythmogenic cardiomyopathy, LGE >9% of LV mass, or fatty replacement predict arrhythmic risk in patients with non-dilated left ventricular cardiomyopathy?
Do overlapping features with arrhythmogenic cardiomyopathy, LGE >9% of LV mass, or fatty replacement predict arrhythmic risk in patients with non-dilated left ventricular cardiomyopathy?
In patients with non-dilated left ventricular cardiomyopathy, LGE >9% of LV mass, fatty replacement, and overlapping features with arrhythmogenic cardiomyopathy are significant predictors of arrhythmic events.
No takes yet. Share an insight, caveat, or question.
LGE assessment may aid arrhythmic stratification in NDLVC; leaves open whether it should guide therapy without prospective validation.
Gueli et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: